Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/8583
Title: Effects of topiramate on peripheral nerve excitability
Authors: Erdogan, Çağdaş
Yücel, M.
Akgün, H.
Kaşkç, T.
Semai Bek, V.
Gökçil, Z.
Keywords: Migraine
Nerve conduction
Nerve excitability
Rheobase
Strength duration time
Topiramate
topiramate
adult
article
clinical article
controlled study
female
human
male
median nerve
migraine
nerve conduction
nerve excitability
nerve stimulation
nervous system electrophysiology
peripheral nerve
Action Potentials
Adult
Anticonvulsants
Electromyography
Epilepsy
Evoked Potentials, Motor
Evoked Potentials, Somatosensory
Female
Fructose
Humans
Neural Conduction
Peripheral Nerves
Wrist
Abstract: PURPOSE: Antiepileptic drugs are generally used to control the cortical hyperexcitable states. But some of them are also effective on the peripheral nervous system, so they may be used in some states like neuropathic pain. Several recent reports suggest the possible effects of antiepileptic drugs on peripheral nerve excitability. Strength duration time properties gives an indirect idea about the persistent, paranodal sodium (Na) channels and may indirectly reflect the peripheral nerve excitability. Topiramate suppresses the cortical hyperexcitability, but previous studies could not prove a significant effect of topiramate on peripheral nerves. The aim of this study is to investigate the probable nerve excitability changes caused by topiramate. METHODS: Forty migraine patients and 40 controls were included in the study. Median motor and sensory conduction parameters were recorded. Strength duration properties were also recorded from abductor pollicis longus muscle, with the stimulation of median nerve. The electrophysiological studies were repeated 4 weeks after the initiation of topiramate in the treatment group. RESULTS: Nerve conduction parameters were not significantly affected by 4-week topiramate treatment. But the strength duration time constant decreased significantly, reflecting a reduction in the excitability. This decrement seemed to be more obvious in those in whom topiramate was also clinically useful. CONCLUSIONS: The method used demonstrated a probable effect of topiramate on the peripheral nerve excitability. Copyright © 2012 by the American Clinical Neurophysiology Society.
URI: https://hdl.handle.net/11499/8583
https://doi.org/10.1097/WNP.0b013e318257c0a0
ISSN: 0736-0258
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

6
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

6
checked on Jul 10, 2024

Page view(s)

30
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.